US Minimally Invasive Surgery Market Size to Exceed USD 16.01 Billion by 2034

The US minimally invasive surgery market size surpassed USD 10.9 billion in 2024 and is predicted to reach around USD 16.01 billion by 2034, registering a CAGR of 3.91% from 2025 to 2034.

Highlights of the US Minimally Invasive Surgery Market

• By application, the orthopedic segment held a dominant presence in the market in 2024.
• By application, the cardiac surgery segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By device, the handheld instruments segment accounted for a considerable share of the market in 2024.
• By device, the electrosurgical segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By end use, the hospital segment led the market.
• By end use, the ambulatory surgical centers segment is set to experience the fastest rate of market growth from 2025 to 2034.

Industry Valuation and Growth Rate Projection

The U.S. market for minimally invasive surgery is expanding significantly because people want safer and faster surgery. Minimally invasive surgery involves using small incisions, tiny tools, and cameras to do surgery, which makes incision size, pain, recovery time, and hospital stay shorter. Physicians have been using minimally invasive surgery for many surgeries, including heart surgery, stomach surgery, and joint surgery.

A growing number of physicians now perform minimally invasive surgery with new technologies for minimally invasive surgery, like robotic surgery and greater imaging. Because many clinics and hospitals favor this type of surgery, there is a growing demand for this type of surgery. The growing population of elderly people who often require surgery is also favoring this option. The U.S. market for minimally invasive surgery is expected to grow significantly.

What are the Market Trends in the US Minimally Invasive Surgery Market?

The market trends in the U.S. minimally invasive surgery market indicate a rise in robotic-assisted surgeries, increased usage of laparoscopy and endoscopy, increased demand for outpatient surgery, and increased interest in cosmetic and weight-loss procedures.

• Hospitals in the U.S. are utilizing robots such as the da Vinci robot due to their increased accuracy and faster recovery times.
• Laparoscopic and endoscopic instruments are quickly becoming the most popular tools for performing small-cut surgery in the U.S.
• More Americans are electing to have surgery done the same day in surgery outpatient centers, so they do not have to stay at a hospital, and they save money.
• There is an increase in interest in bariatric (weight-loss) and minimally invasive cosmetic surgical procedures in the U.S.

What are the Restraints in the US Minimally Invasive Surgery Market?

Restraints in the U.S. minimally invasive surgery market include High costs of surgical devices, a lack of surgeons trained for new minimally invasive procedures, and increased potential for surgical errors in difficult cases.

• There is a high market price for advanced and robotic devices, making it difficult for small hospitals to afford them.
• Not every U.S. physician is trained and skilled in minimally invasive techniques, limiting access to these procedures.
• For some complex surgeries, employing small tools can create an increase in surgical error potential or time to completion of the surgery.

What are the Opportunities in the US Minimally Invasive Surgery Market?

Growth opportunities in the U.S. minimally invasive surgery market are linked to the aging population in the U.S., robust government support for advanced health care, and growing patient volumes for outpatient and ambulatory surgery centers.

• Older adults regularly necessitate surgery, both minor and serious in scope, and tend to prefer methods that lessen recovery time, including minimally invasive techniques.
• The U.S. is also no stranger to sizable amounts of health programming and funding that allow hospitals to utilize advanced surgical technologies.
• Outpatient and ambulatory surgery centers are multiplying at enormous rates and creating more options for patients to undergo minimally invasive surgery.

Recent Developments in the US Minimally Invasive Surgery Market:

• In June 2025, Yale Medicine began a new treatment for Normal Pressure Hydrocephalus (NPH), providing better diagnosis through spinal taps and imaging. Patients have stated they are now able to walk better and have improved their memory after their shunt surgeries, which has led some physicians to believe that we may be able to start treatment on patients sooner and with a more accurate diagnosis.
• In June 2025, for the first time in history, a surgeon in the U.S. performed remote robotic surgery on a patient in Africa using 5G and robotic technology. This operation documented a breakthrough moment in healthcare access.
• In February 2025, AdventHealth Ocala received the 2025 Women's Choice Award® as one of America's best hospitals for minimally invasive surgery. In addition to the award, the survey and announcement indicated excellence, patient safety, lower complication rates, and a commitment to women's advanced surgical care.

US Minimally Invasive Surgery Market Share, By Product Type, 2024 (%)

• Surgical Devices & Instruments – Holds 31%, providing essential tools required across all surgical procedures, dominating due to universal usage and high replacement frequency.
• Imaging & Monitoring Systems – Represents 19%, supporting visualization and real-time surgical data, not dominating because adoption depends on procedure complexity and capital cost.
• Robotic-Assisted Surgery (RAS) Systems – Captures 25%, enabling high-precision minimally invasive operations, gaining strong momentum due to rapid hospital technology upgrades.
• Accessories & Consumables – Also accounts for 25%, supplying disposable and procedure-specific components, gaining strength through recurring demand and high usage volumes.

US Minimally Invasive Surgery Market Share, By Application, 2024 (%)

• Orthopedic Surgery – Holds 19%, driven by joint replacement and trauma cases, dominating due to rising aging population and sports injury incidence.
• Cardiovascular Surgery – Represents 17%, treating heart and vascular diseases, gaining momentum as chronic cardiac cases increase globally.
• Gastrointestinal Surgery – Accounts for 13%, covering digestive system procedures, moderate share due to increasing adoption of minimally invasive techniques.
• Gynecological Surgery – Holds 12%, supporting reproductive and pelvic treatments, steady share driven by rising women’s health awareness.
• Urological Surgery – Represents 11%, managing kidney and urinary disorders, gaining gradual traction with rising prostate and urinary conditions.
• Neurosurgery – Holds 8%, focused on brain and spine disorders, not dominating due to high complexity and limited specialized centers.
• Ophthalmic Surgery – Accounts for 6%, covering eye-related corrections, not dominating due to narrower procedure scope.
• Cosmetic & Plastic Surgery – Captures 14%, addressing corrective and aesthetic enhancements, gaining momentum as elective surgery demand grows.

US Minimally Invasive Surgery Market Share, By Technology, 2024 (%)

• Laparoscopic Surgery – Holds 24%, enabling minimally invasive abdominal procedures, dominating due to broad clinical adoption and faster recovery outcomes.
• Endoscopic Surgery – Represents 22%, using flexible scopes for internal visualization and intervention, gaining strength as outpatient procedures increase.
• Robotic-Assisted Surgery – Accounts for 18%, advancing precision and surgeon ergonomics, rapidly gaining momentum through high-tech integration.
• Non-robotic Minimally Invasive Surgery – Holds 14%, involving manual minimally invasive techniques, steady share but not dominating as robotics expand.
• Catheter-Based Interventions – Represents 15%, key in cardiovascular and vascular access applications, growing with rising interventional cardiology cases.
• Laser-Assisted Surgery – Accounts for 7%, used for precision tissue removal and cosmetic treatments, not dominating due to high equipment costs and limited procedure scope.

US Minimally Invasive Surgery Market Share, By End-User, 2024 (%)

• Hospitals – Hold 54%, delivering a broad range of complex procedures, dominating due to advanced infrastructure and higher surgical volumes.
• Ambulatory Surgical Centers – Represent 22%, providing outpatient surgeries, gaining momentum as demand rises for cost-efficient same-day procedures.
• Specialty Clinics – Account for 14%, focused on specific disciplines like orthopedics, ophthalmology, and dermatology, steady share driven by specialized expertise.
• Academic & Research Institutes – Hold 10%, supporting training and surgical innovation, not dominating due to lower procedure volume.